A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer's Disease

  • Jamal Q
  • Siddiqui M
  • Alharbi A
  • et al.
16Citations
Citations of this article
21Readers
Mendeley users who have this article in their library.
Get full text

Abstract

© 2020 Bentham Science Publishers. Keeping in view the public health-related issues of Alzheimer’s disease (AD), its unpredictable occurrence and progression indicate the needs for best treatment options. The present bioinformatics study explores the binding pattern and molecular interactions between human acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) enzymes with natural compounds from Bacopa monnieri. The docking analysis between natural compounds as a ligand and AChE, BuChE as a receptor was completed using MGL tools Autodock 4.2 module. The analysis of the hydrophobic interactions, inhibition constants, and hydrogen bonds may indicates that they play a significant role in finding out the interacting position at the active site. However, after analyzing the binding energy (δG), the documented data shows that bacoside X, bacoside A, 3-beta-D-glucosylstigmasterol and daucosterol could be good inhibitors in the inhibition of AChE and BuChE activities. Therefore, our study indicates that the inhibition constants of the aforesaid natural compounds of Bacopa can be utilized for the development of inhibitors.

Cite

CITATION STYLE

APA

Jamal, Q. M. S., Siddiqui, M. U., Alharbi, A. H., Albejaidi, F., Akhtar, S., Alzohairy, M. A., … Kesari, K. K. (2020). A Computational Study of Natural Compounds from Bacopa monnieri in the Treatment of Alzheimer’s Disease. Current Pharmaceutical Design, 26(7), 790–800. https://doi.org/10.2174/1381612826666200102142257

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free